Valuation: PeptiDream Inc.

Market Cap 120B 730M 641M 597M 549M 1.03B 69.76B 1.05B 7.08B 2.77B 34.6B 2.74B 2.68B P/E 2026 *
9.44x
P/E 2027 * 9.53x
Enterprise Value 89.86B 549M 482M 449M 413M 773M 52.44B 787M 5.32B 2.08B 26.01B 2.06B 2.02B EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.72x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.64%
1 day-2.67%
1 week-4.57%
Current month-12.61%
1 month-9.28%
3 months-21.49%
6 months-43.27%
Current year-43.84%
1 week 923.9
Extreme 923.9
972.9
1 month 923.9
Extreme 923.9
1,092
Current year 916
Extreme 916
1,788
1 year 916
Extreme 916
1,818.5
3 years 916
Extreme 916
3,060
5 years 916
Extreme 916
4,680
10 years 916
Extreme 916
6,540
Manager TitleAgeSince
Chief Executive Officer 51 01/01/2022
Chief Operating Officer - 02/07/2026
Chief Tech/Sci/R&D Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 51 01/08/2008
Director/Board Member 51 01/09/2017
Director/Board Member 55 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-4.57%-45.66%-49.32% 750M
-2.25%+1.55%+50.84%+70.04% 56.19B
-1.32%-0.97%+38.41%+77.52% 54.83B
+1.16%-0.43%-18.49%-14.42% 23.04B
-0.26%-3.77%+2.73%+389.60% 22.7B
-0.21%+0.84%+22.48%-7.92% 20.23B
0.00%+3.00%+27.41%-29.52% 17.83B
-0.97%+0.89%+37.28%+539.62% 15.65B
-6.69%-5.11%+166.00%+304.89% 15.24B
+0.50%-0.18%+26.20%+182.22% 14.03B
Average -1.28%-0.22%+30.72%+146.27% 24.05B
Weighted average by Cap. -1.23%+0.41%+37.38%+131.49%

Financials

2026 *2027 *
Net sales 44.71B 273M 240M 223M 205M 385M 26.09B 391M 2.65B 1.04B 12.94B 1.03B 1B 46.18B 282M 248M 231M 212M 398M 26.95B 404M 2.74B 1.07B 13.37B 1.06B 1.04B
Net income 12.76B 77.97M 68.42M 63.72M 58.61M 110M 7.45B 112M 756M 296M 3.69B 293M 286M 12.62B 77.06M 67.63M 62.98M 57.93M 109M 7.36B 110M 747M 292M 3.65B 289M 283M
Net Debt -29.67B -181M -159M -148M -136M -255M -17.32B -260M -1.76B -688M -8.59B -681M -666M -40.03B -245M -215M -200M -184M -345M -23.36B -350M -2.37B -928M -11.59B -918M -898M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
745
Date Price Change Volume
28/07/26 ¥930.30 -2.67% 1,081,100
27/07/26 ¥955.80 +1.72% 642,500
24/07/26 ¥939.60 -1.38% 1,227,900
23/07/26 ¥952.70 -0.18% 681,100
22/07/26 ¥954.40 -2.06% 854,900
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
930.30JPY
Average target price
2,750.00JPY
Spread / Average Target
+195.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock